INP-1750

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameINP-1750
Drug Alias Namevirulence blocker (Creative Antibiotics/Syngene)virulence blocker (Innate/Syngene)INP-1855INP-1750
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiarrheaPseudomonas Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenIndia
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCreative Antibiotics Sweden AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSyngene International LtdCreative Antibiotics Sweden AB
Active IndicationsN/A
Inactive IndicationsDiarrheaPseudomonas Infections

Other Information

ATC CodeN/A
Related LinksN/A